These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15325034

  • 1. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
    Theocharis S, Margeli A, Vielh P, Kouraklis G.
    Cancer Treat Rev; 2004 Oct; 30(6):545-54. PubMed ID: 15325034
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, Ferretti C, Dianzani MU, Barrera G.
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [Abstract] [Full Text] [Related]

  • 3. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T.
    Anticancer Res; 2004 Jun; 24(3a):1409-16. PubMed ID: 15274302
    [Abstract] [Full Text] [Related]

  • 4. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R, Matsuyama M, Hase T, Tsuchida K, Kuratsukuri K, Kawahito Y, Sano H, Segawa Y, Nakatani T.
    Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis.
    Margeli A, Kouraklis G, Theocharis S.
    Angiogenesis; 2003 Dec; 6(3):165-9. PubMed ID: 15041792
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents.
    Theocharisa S, Margeli A, Kouraklis G.
    Curr Med Chem Anticancer Agents; 2003 May; 3(3):239-51. PubMed ID: 12769781
    [Abstract] [Full Text] [Related]

  • 7. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.
    Chang TH, Szabo E.
    Cancer Res; 2000 Feb 15; 60(4):1129-38. PubMed ID: 10706135
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S, Roman J.
    Anticancer Drugs; 2007 Mar 15; 18(3):237-44. PubMed ID: 17264754
    [Abstract] [Full Text] [Related]

  • 9. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
    Ibabe A, Herrero A, Cajaraville MP.
    Toxicol In Vitro; 2005 Sep 15; 19(6):725-35. PubMed ID: 15964169
    [Abstract] [Full Text] [Related]

  • 10. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P, Seifert M, Tilgen W, Reichrath J.
    J Cell Physiol; 2007 Jul 15; 212(1):1-12. PubMed ID: 17443682
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 15; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J, Lu H, Huang R, Lin D, Wu X, Lin Q, Wu X, Zheng J, Pan X, Peng J, Song Y, Zhang M, Hou M, Chen F.
    Cancer Chemother Pharmacol; 2005 Oct 15; 56(4):400-8. PubMed ID: 15838654
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor gamma and cancers.
    Koeffler HP.
    Clin Cancer Res; 2003 Jan 15; 9(1):1-9. PubMed ID: 12538445
    [Abstract] [Full Text] [Related]

  • 14. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD, Castillo ME, Goldenberg DM, Blumenthal RD.
    Anticancer Drugs; 2007 Jun 01; 18(5):525-34. PubMed ID: 17414621
    [Abstract] [Full Text] [Related]

  • 16. PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes.
    Roth AD, Leisewitz AV, Jung JE, Cassina P, Barbeito L, Inestrosa NC, Bronfman M.
    J Neurosci Res; 2003 May 15; 72(4):425-35. PubMed ID: 12704804
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T.
    Br J Dermatol; 2004 Oct 15; 151(4):766-75. PubMed ID: 15491415
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA, Piqueras L, Bishop-Bailey D.
    Pharmacol Ther; 2006 Jun 15; 110(3):371-85. PubMed ID: 16168490
    [Abstract] [Full Text] [Related]

  • 19. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr 15; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug 15; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.